Overview

A Sequential Single and Multiple Ascending Dose (SAD/MAD) Study of SK10 Powders in Healthy Adult Subjects

Status:
Completed
Trial end date:
2024-02-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of orally administered SK10 powders in healthy adult subjects at three dose levels, following single and multiple doses.
Phase:
Phase 1
Details
Lead Sponsor:
Guangzhou Zhiyi Biotechnology Co., Ltd.